Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

22 Nov 2020

Abstract excerpt

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. Elucidating the genetic architecture of additional AD-related phenotypic traits, ideally those linked to the underlying disease process, holds great...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Genetic Associations and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33223526
DOI: 10.1038/s41398-020-01074-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetPMID 33223526Read ↗

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetSemantic proximity Read ↗

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkersSemantic proximity Read ↗

Genome-wide meta-analysis of CSF biomarkers in Alzheimer’s disease and Parkinson’s disease cohortsSemantic proximity Read ↗

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.Semantic proximity Read ↗

Genome-wide association study of Alzheimer’s disease brain imaging biomarkers and neuropsychological phenotypes in the EMIF-AD Multimodal Biomarker Discovery datasetSemantic proximity Read ↗

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkersSemantic proximity Read ↗

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery DatasetSemantic proximity Read ↗

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioningSemantic proximity Read ↗

Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.Semantic proximity Read ↗

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.Semantic proximity Read ↗

Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1.Semantic proximity Read ↗

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.